Scaling up Biodefense

The US is ramping up its capabilities for producing vaccines and other medical countermeasures to respond to epidemics, pandemics, and bioterrorism events through a $440 million initiative that is funding three centers around the country, called the Centers for Innovation in Advanced Development and Manufacturing program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.